The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tuberculosis is responsible for one in four of all avoidable adult deaths in developing countries. Increased frequency and accelerated fatality of the disease among individuals infected with human immunodeficiency virus has raised worldwide concern that control programmes may be inadequate, and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in several recent fatal outbreaks in the United States. Isonicotinic acid hydrazide (isoniazid, INH) forms the core of antituberculosis regimens; however, clinical isolates that are resistant to INH show reduced catalase activity and a relative lack of virulence in guinea-pigs. Here we use mycobacterial genetics to study the molecular basis of INH resistance. A single M. tuberculosis gene, katG, encoding both catalase and peroxidase, restored sensitivity to INH in a resistant mutant of Mycobacterium smegmatis, and conferred INH susceptibility in some strains of Escherichia coli. Deletion of katG from the chromosome was associated with INH resistance in two patient isolates of M. tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An INH-resistant strain of mc2155 was shown to become sensitive upon expression of the M. tuberculosis catalase-peroxidase gene, katG, suggesting that susceptibility to INH requires the expression of katG (127).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [127]
Citations
Cites
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Self-citationWayne, L. G., & Diaz, G. A. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90200-9 · Cited by 173
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Mulvey, M. R., Sorby, P. A., Triggs‐Raine, B. L., & Loewen, P. C. (1988) · Gene · doi:10.1016/0378-1119(88)90498-2 · Cited by 121
Research works printed but not linked: 4
- Murray, C. J. L., Styblo, K. & Rouillon, A. Bull. Int. Union against Tuberculosis and Lung Disorders 65, 6–24 (1990).
- Cohn, M. L., Kovitz, C., Oda, U. & Middlebrook, G. Am. Rev. Tuberc. 70, 641–664 (1954).
- Youatt, J. Am. Rev. respir. Dis. 99, 729–749 (1969).
- Heym, B. & Cole, S. T. Res. Microbiol. (in the press).
Cited by
Items 301–400 of 1,000
Mutsuda, M., Ishikawa, T., Takeda, T., & Shigeoka, S. (1996) · Biochemical Journal · doi:10.1042/bj3160251 · Cited by 72
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria
Cox, J. A. G., Abrahams, K. A., Alemparte, C., Ghidelli, S., Rullás, J., Angulo‐Barturen, Í., Singh, A., Gurcha, S. S., Nataraj, V., Bethell, S., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2015.6 · Cited by 73
Ruíz, M., Torres, M. J., Llanos, A. C., Arroyo, A., Palomares, J. C., & Aznar, J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1585-1589.2004 · Cited by 71
Palomino, A., Gewurz, D., DeVine, L., Zajmi, U., Moralez, J., Abu-Rumman, F., Smith, R. P., & Lopatkin, A. J. (2022) · The ISME Journal · doi:10.1038/s41396-022-01329-1 · Cited by 72
State of the Art. Potential Etiologic Agents in Sarcoidosis
Möller, D. R. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200608-155ms · Cited by 70
Maccari, R., Ottanà, R., Monforte, F., & Vigorita, M. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.294-299.2002 · Cited by 70
Lavender, C. J., Globan, M., Sievers, A. S., Billman‐Jacobe, H., & Fyfe, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4068-4074.2005 · Cited by 70
Chollet, A., Maveyraud, L., Lherbet, C., & Bernardes‐Génisson, V. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.047 · Cited by 70
Herrera, L., Molina, T., Sáiz, P. A., Sáez-Nieto, J. A., & Jiménez, M. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.144-147.2005 · Cited by 70
Stoeckle, M. Y., Guan, L. L., Riegler, N., Weitzman, I., Kreiswirth, B. N., Kornblum, J. S., Laraque, F., & Riley, L. W. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1063 · Cited by 70
Laboratory diagnostic aspects of drug resistant tuberculosis
Linda, M. P. (2004) · Frontiers in bioscience · doi:10.2741/1290 · Cited by 77
Resistance to Antitubercular Drugs
Basso, L. A., & Blanchard, J. S. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4897-3_7 · Cited by 84
Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation
Zeng, S., Soetaert, K., Ravon, F., Vandeput, M., Bald, D., Kauffmann, J., Mathys, V., Wattiez, R., & Fontaine, V. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01841-18 · Cited by 72
Prodrugs for the Treatment of Neglected Diseases
Chung, M. C., Ferreira, E. I., dos Santos, J. L., Giarolla, J., Rando, D. G. G., de Almeida, A. E., Bosquesi, P. L., Menegon, R. F., & Blau, L. (2008) · Molecules · doi:10.3390/molecules13030616 · Cited by 75
Drug development against tuberculosis: Impact of alkaloids
Mishra, S. K., Tripathi, G., Kishore, N., Singh, R. K., Singh, A. K., & Tiwari, V. K. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.005 · Cited by 72
Color selection with a hygromycin-resistance-based Escherichia coli-mycobacterial shuttle vector
Howard, N. S., Gomez, J. E., Ko, C. G., & Bishai, W. R. (1995) · Gene · doi:10.1016/0378-1119(95)00597-x · Cited by 68
CHAUHAN, R., & Mande, S. C. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540209 · Cited by 68
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs
Chauhan, A., Kumar, M., Kumar, A., & Kanchan, K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119301 · Cited by 71
Weinstein, E. A., Liu, L., Ordoñez, A. A., Wang, H., Hooker, J. M., Tonge, P. J., & Jain, S. K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01644-12 · Cited by 67
Transcriptional Regulation of furA and katG upon Oxidative Stress in Mycobacterium smegmatis
Milano, A., Forti, F., Sala, C., Riccardi, G., & Ghisotti, D. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6801-6806.2001 · Cited by 74
Lety, M. A., Nair, S., Berche, P., & Escuyer, V (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2629 · Cited by 65
van Doorn, H. R., de Haas, P. E. W., Kremer, K., Vandenbroucke‐Grauls, C. M. J. E., Borgdorff, M. W., & van Soolingen, D. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01495.x · Cited by 66
Identification ofMycobacterium tuberculosisAntigens of High Serodiagnostic Value
Ireton, G. C., Greenwald, R., Liang, H., Esfandiari, J., Lyashchenko, K. P., & Reed, S. G. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00198-10 · Cited by 70
Antitubercular Isoniazid and Drug Resistance of Mycobacterium tuberculosis — A Review
Scior, T., Morales, I. M., Garcés‐Eisele, S. J., Domeyer, D. M., & Laufer, S. (2002) · Archiv der Pharmazie · doi:10.1002/ardp.200290005 · Cited by 66
New horizons in the treatment of tuberculosis
Barry, C. E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00163-9 · Cited by 73
Ducasse-Cabanot, S., Cohen‐Gonsaud, M., Marrakchi, H., Nguyen, M., Zerbib, D., Bernadou, J., Daffé, M., Labesse, G., & Quémard, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.242-249.2004 · Cited by 76
Chouchane, S., Girotto, S., Yu, S., & Magliozzo, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207916200 · Cited by 70
Emerging therapeutic targets in tuberculosis: post-genomic era
Khasnobis, S., Escuyer, V. E., & Chatterjee, D. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.1.21 · Cited by 77
Free radical detoxification in Giardia duodenalis
Brown, D. M., Upcroft, J., & Upcroft, P. (1995) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(95)00065-9 · Cited by 65
Sandy, J., Holton, S. J., Fullam, E., Sim, E., & Noble, M. E. M. (2005) · Protein Science · doi:10.1110/ps.041163505 · Cited by 65
Current status and future development of antitubercular chemotherapy
Besra, G. S., & Kremer, L. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.8.1033 · Cited by 69
Chemistry and Redox Biology of Mycothiol
Reyes, A. M., Pedre, B., De Armas, M. I., Tossounian, M.-A., Radi, R., Messens, J., & Trujillo, M. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7074 · Cited by 64
“…dihydrolipoamide succinyl transferase/NADH, have been described (15, 57) Theinteractions of MSH with catalase peroxidase (KatG), the main heme-dependent peroxidase expressed in mycobacteria that is responsible for the activation of the prodrug isoniazid (INH), remain to be investigated (52, 165).”
Vilchèze, C., Copeland, J., Keiser, T. L., Weisbrod, T. R., Washington, J. M., Jain, P., Malek, A., Weinrick, B. C., & Jacobs, W. R. (2018) · mBio · doi:10.1128/mbio.00938-18 · Cited by 66
Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall
Batt, S. M., Burke, C., Moorey, A. R., & Besra, G. S. (2020) · The Cell Surface · doi:10.1016/j.tcsw.2020.100044 · Cited by 80
Comparative mycobacterial genomics
Cole, S. T. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80090-8 · Cited by 63
Self-citationMolecular action of anti-mycobacterial agents
Chopra, I., & Brennan, P. J. (1998) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(98)80001-4 · Cited by 77
Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge.
Murray, M. B., & Nardell, E. A. (2002) · Europe PMC (PubMed Central) · Cited by 63
Panas, M. W., Jain, P., Yang, H., Mitra, S., Biswas, D., Wattam, A. R., Letvin, N. L., & Jacobs, W. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414207111 · Cited by 62
Sharma, A., Rosa, M. D., Singla, N., Singh, G., Barnwal, R. P., & Pandey, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01833 · Cited by 64
Dhandayuthapani, S., Mudd, M. H., & Deretic, V. P. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.7.2401-2409.1997 · Cited by 69
A Ribosomal Gene Mutation in Streptomycin-ResistantMycobacterium tuberculosis Isolates
Douglass, J., & Steyn, L. M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1505 · Cited by 69
First– and Second–Line Drugs and Drug Resistance
Nath, H., & Ryoo, S. (2013) · InTech eBooks · doi:10.5772/54960 · Cited by 70
van Doorn, H. R., Claas, E. C. J., Templeton, K. E., van der Zanden, A. G. M., Vije, A. T. K., de Jong, M. D., Dankert, J., & Kuijper, E. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4630-4635.2003 · Cited by 61
Analysis of Portable Impactor Performance for Enumeration of Viable Bioaerosols
Yao, M., & Mainelis, G. (2007) · Journal of Occupational and Environmental Hygiene · doi:10.1080/15459620701407388 · Cited by 61
Isakova, J. T., Sovhozova, N. A., Vinnikov, D. V., Goncharova, Z. K., Talaibekova, E., Aldasheva, N., & Aldashev, A. A. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1168-x · Cited by 61
Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control
Zhang, Y., & Young, D. B. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90117-a · Cited by 61
Self-citationThe mycelium-associated Streptomyces reticuli catalase-peroxidase, its gene and regulation by FurS
Zou, P.-J., Borovok, I., de Orué Lucana, D. O., Müller, D., & Schrempf, H. (1999) · Microbiology · doi:10.1099/13500872-145-3-549 · Cited by 61
Stavrum, R., Myneedu, V. P., Arora, V. K., Ahmed, N., & Grewal, H. M. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004540 · Cited by 60
High-Dose Isoniazid Therapy for Isoniazid-Resistant Murine Mycobacterium tuberculosis Infection
Cynamon, M. H., Zhang, Y., Harpster, T. S., Cheng, S. J., & DeStefano, M. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2922 · Cited by 60
Self-citationLohrasbi, V., Talebi, M., Bialvaei, A. Z., Fattorini, L., Drancourt, M., Heidary, M., & Darban‐Sarokhalil, D. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.12.002 · Cited by 63
Role of Superoxide in Catalase-Peroxidase-Mediated Isoniazid Action against Mycobacteria
Wang, J., Burger, R. M., & Drlica, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.709 · Cited by 60
Pretorius, G. S., van Helden, P. D., Sirgel, F. A., Eisenach, K. D., & Victor, T. C. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2276 · Cited by 64
Biochemical and genetic analyses of a catalase from the anaerobic bacterium Bacteroides fragilis
Rocha, E. R., & Smith, C. J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.11.3111-3119.1995 · Cited by 60
Gemma, S., Savini, L., Altarelli, M., Tripaldi, P., Chiasserini, L., Coccone, S. S., Kumar, V., Camodeca, C., Campiani, G., Novellino, E., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.051 · Cited by 59
A Novel Mechanism of Growth Phase-dependent Tolerance to Isoniazid in Mycobacteria
Niki, M., Niki, M., Tateishi, Y., Ozeki, Y., Kirikae, T., Lewin, A., Inoue, Y., Matsumoto, M., Dahl, J. L., Ogura, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333385 · Cited by 70
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Jhun, B. W., & Koh, W. (2019) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2019.0065 · Cited by 59
Canan Koch, S. S., Dardashti, L. J., Cesario, R. M., Croston, G. E., Boehm, M. F., Heyman, R. A., & Nadzan, A. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980621r · Cited by 59
A molecular switch and electronic circuit modulate catalase activity in catalase‐peroxidases
Carpena, X., Wiseman, B., Deemagarn, T., Singh, R., Switala, J., Ivancich, A., Fita, I., & Loewen, P. C. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400550 · Cited by 59
Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis
Rouse, D. A., & Morris, S. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1427-1433.1995 · Cited by 59
Colin, J., Wiseman, B., Switala, J., Loewen, P. C., & Ivancich, A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901402v · Cited by 58
Multidrug-Resistant Tuberculosis Drug Susceptibility and Molecular Diagnostic Testing
Kalokhe, A. S., Lee, J. C., Ray, S. M., Anderson, A. M. L., Nguyen, M. L., Wang, Y. F., Shafiq, M., & Metchock, B. G. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31825d32c6 · Cited by 58
Haydel, S. E. (2010) · Pharmaceuticals · doi:10.3390/ph3072268 · Cited by 60
Luò, T., Zhao, M., Li, X., Xu, P., Gui, X., Pickerill, S., DeRiemer, K., Mei, J., & Gao, Q. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00964-09 · Cited by 58
Biologically Active Heteroarotinoids Exhibiting Anticancer Activity and Decreased Toxicity
Benbrook, D. M., Madler, M. M., Spruce, L. W., Birckbichler, P. J., Nelson, E. C., Subramanian, S., Weerasekare, G. M., Gale, J. B., Patterson, M. K., Wang, B., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970196m · Cited by 58
Vargas, M. D. C., Encarnación‐Guevara, S., Dávalos, A., Reyes-Pérez, A., Mora, Y., Santos, A. G.-D. L., Brom, S., & Mora, J. (2003) · Microbiology · doi:10.1099/mic.0.25909-0 · Cited by 61
Beard, R. L., Colon, D. F., Song, T. K., Davies, P. J., Kochhar, D. M., & Chandraratna, R. A. S. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960386h · Cited by 58
Identification of the First Retinoid X Receptor Homodimer Antagonist
Koch, S. S. C., Dardashti, L. J., Hebert, J. J., White, S. K., Croston, G. E., Flatten, K. S., Heyman, R. A., & Nadzan, A. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960311d · Cited by 58
Loss of oxyR in Mycobacterium tuberculosis
Deretic, V. P., Song, J., & Pagán-Ramos, E. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01112-8 · Cited by 58
Esterase mutation is a mechanism of resistance to antimalarial compounds
Istvan, E. S., Mallari, J. P., Corey, V. C., Dharia, N. V., Marshall, G. R., Winzeler, E. A., & Goldberg, D. E. (2017) · Nature Communications · doi:10.1038/ncomms14240 · Cited by 57
Amir, W., Farid, M., Ishaq, H. K., Farid, S., Zubair, M., Alharby, H. F., Bamagoos, A. A., Rizwan, M., Raza, N., Hakeem, K. R., et al. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.127247 · Cited by 53
Wang, R., Wennerstrom, D. E., Cao, W.-W., Khan, A. A., & Cerniglia, C. E. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.10.4300-4304.2000 · Cited by 57
Comparative Genomic Analysis of Mycobacterium tuberculosis Drug Resistant Strains from Russia
Ilina, E. N., Shitikov, E. A., Ikryannikova, L. N., Alekseev, D. G., Kamashev, D., Malakhova, M. V., Parfenova, T. V., Afanas'ev, M. V., Ischenko, D. S., Bazaleev, N. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056577 · Cited by 60
Parasite plastids: approaching the endgame
Wilson, R. J. (2005) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793104006591 · Cited by 60
Angula, K. T., Legoabe, L. J., & Beteck, R. M. (2021) · Pharmaceuticals · doi:10.3390/ph14050461 · Cited by 59
Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid
Bulatović, V. M., Wengenack, N. L., Uhl, J. R., Hall, L., Roberts, G. D., Cockerill, F. R., & Rusnak, F. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2765-2771.2002 · Cited by 56
van Doorn, H. R., Kuijper, E. J., ENDE, A. V. D., Welten, A. G. A., van Soolingen, D., de Haas, P. E. W., & Dankert, J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1591-1594.2001 · Cited by 56
Zinc limitation triggers anticipatory adaptations in Mycobacterium tuberculosis
Dow, A., Sule, P., O’Donnell, T. J., Burger, A., Mattila, J. T., Antonio, B., Vergara, K., Marcantonio, E., Adams, L. G., James, N., et al. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009570 · Cited by 55
“On the other hand, cultures from ZLM experienced significantly more rapid killing when treated with isoniazid, consistent with the upregulation of KatG (confirmed in mc(2) 6206 strain with western blot, S11 Fig), the isoniazidactivating enzyme in Mtb [48] (Fig 5A).”
BackgroundAndo, H., Kitao, T., Miyoshi‐Akiyama, T., Kato, S., Mori, T., & Kirikae, T. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07547.x · Cited by 55
The evolving biology of Mycobacterium tuberculosis drug resistance
Jones, R. M., Adams, K. N., Eldesouky, H. E., & Sherman, D. R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1027394 · Cited by 60
da Silva, P. E. A., Ramos, D. F., Bonacorso, H. G., de la Iglesia, A. I., Oliveira, M. R., Coelho, T. S., Navarini, J., Morbidoni, H. R., Zanatta, N., & Martins, M. A. P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.03.019 · Cited by 55
Characterization ofpncAMutations of Pyrazinamide-ResistantMycobacterium tuberculosisin Korea
Lee, K. W., Lee, J. M., & Jung, K. S. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.5.537 · Cited by 55
Hanoulle, X., Wieruszeski, J., Rousselot‐Pailley, P., Landrieu, I., Locht, C., Lippens, G. M., & Baulard, A. R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl332 · Cited by 55
TB: the return of the phage. A review of fifty years of mycobacteriophage research.
McNerney, R. (1999) · PubMed · Cited by 55
Leprosy, tuberculosis, and the new genetics
Young, D. B., & Cole, S. T. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.1-6.1993 · Cited by 65
Self-citationDrobniewski, F. A., Rüsch–Gerdes, S., & Hoffner, S. E. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01813.x · Cited by 64
Genetics and pulmonary medicine bullet 5: Genetics of drug resistant tuberculosis
Telenti, A. (1998) · Thorax · doi:10.1136/thx.53.9.793 · Cited by 62
The molecular basis of isoniazid resistance in Mycobacterium tuberculosis
Heym, B., Saint‐Joanis, B., & Cole, S. T. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0208 · Cited by 54
Self-citationAlahari, A., Alibaud, L., Trivelli, X., Gupta, R., Lamichhane, G., Reynolds, R. C., Bishai, W. R., Guérardel, Y., & Kremer, L. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06604.x · Cited by 62
Rapid Detection of Pyrazinamide-Resistant Mycobacterium tuberculosis by a PCR-Based In Vitro System
Suzuki, Y., Suzuki, A., Tamaru, A., Katsukawa, C., & Oda, H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.2.501-507.2002 · Cited by 66
Deretic, V. P., Pagán-Ramos, E., Zhang, Y., Dhandayuthapani, S., & Via, L. E. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1557 · Cited by 54
Self-citationAbate, G., Hoffner, S., Thomsen, V. Ø., & Miörner, H. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00011272 · Cited by 59
Reyes, A. M., Hugo, M., Trostchansky, A., Capece, L., Radí, R., & Trujillo, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.023 · Cited by 53
Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
Lee, J., Ammerman, N. C., Nolan, S. T., Geiman, D. E., Lun, S., Guo, H., & Bishai, W. R. (2012) · Nature Communications · doi:10.1038/ncomms1724 · Cited by 55
Discovery of a cofactor-independent inhibitor ofMycobacterium tuberculosisInhA
Xia, Y., Zhou, Y., Carter, D. S., McNeil, M. B., Choi, W., Halladay, J. S., Berry, P. W., Mao, W., Hernandez, V. S., O’Malley, T., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800025 · Cited by 53
Judge, V., Narasimhan, B., & Ahuja, M. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9948-y · Cited by 53
Fármacos con actividad frente a Mycobacterium tuberculosis
Coll, P. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2009.06.010 · Cited by 67
GENETICS OF DRUG RESISTANCE IN TUBERCULOSIS
Telenti, A. (1997) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70355-5 · Cited by 60
Gene replacement by homologous recombination in Mycobacterium bovis BCG
Norman, E., Dellagostin, O. A., McFadden, J., & Dale, J. W. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02436.x · Cited by 53
Molecular Basis of Drug Resistance in Mycobacterium tuberculosis
Cohen, K. A., Bishai, W. R., & Pym, A. S. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0036-2013 · Cited by 61
Punkvang, A., Saparpakorn, P., Hannongbua, S., Wolschann, P., Beyer, A., & Pungpo, P. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.008 · Cited by 52
Metadata
- Authors
- Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S.
- Affiliations
- Hammersmith Hospital (GB)
- Institut Pasteur (FR)
- Venue
- Nature
- Published
- 1992-08-13
- Volume
- 358
- Issue
- 6387
- Pages
- 591-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2058925610
- Cited by
- 1,299
- References
- 17
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 28 · 2023: 26 · 2022: 35 · 2021: 34 · 2020: 47 · 2019: 45 · 2018: 49 · 2017: 50 · 2016: 36 · 2015: 47 · 2014: 69 · 2013: 37 · 2012: 50
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- isoniazid resistance, Mycobacterium tuberculosis, katG gene, catalase-peroxidase, multidrug resistance, Mycobacterium smegmatis, Escherichia coli, gene deletion, antitubercular agents, tuberculosis
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Catalase, Cloning, Molecular, DNA, Bacterial, Drug Resistance, Microbial, Escherichia coli, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium tuberculosis, Peroxidases, Plasmids, Blotting, Southern, Restriction Mapping, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.